Ketamine use has changed significantly over the past two decades. Once largely confined to niche club scenes, it is now one of the most commonly used drugs among young people in the UK, and the clients presenting to drug services increasingly reflect this shift. Having the right resources available is no longer optional; it is a core part of effective service delivery.
Whether you are working in a community drug service, a sexual health clinic, a young people’s service, or a harm reduction outreach programme, the demand for clear, credible, non-judgemental ketamine information has never been greater. The resources on this page have been developed to meet that need.
Ketamine use: a brief chronology
Understanding how ketamine use has evolved helps services contextualise the needs of their clients and make the case internally for investing in high-quality resources.
1962 — Ketamine is first synthesised by Parke-Davis as a safer alternative to existing anaesthetics. Its dissociative properties make it valuable in medical and veterinary settings.
Late 1960s–70s — Ketamine is used extensively as a battlefield anaesthetic during the Vietnam War and gains widespread adoption in hospital settings worldwide.
1980s — Ketamine begins to appear in recreational contexts in the United States, particularly within psychedelic and experimental communities. Early documentation describes its dissociative and euphoric effects at sub-anaesthetic doses.
1990s — Ketamine becomes associated with rave and club culture in the UK and Europe. Its availability, relatively low cost, and short duration of effect make it popular in nightlife settings. Services begin encountering clients with recreational ketamine use more frequently.
Early 2000s — Reports begin to emerge from urologists and sexual health clinicians of a distinctive pattern of lower urinary tract damage in heavy ketamine users. Ketamine-associated uropathy, now widely known as ketamine bladder, becomes a recognised clinical condition.
2006 onwards — Medical literature on ketamine bladder grows rapidly. Drug services increasingly recognise the need for targeted harm reduction information, as clients present with symptoms they, and sometimes their GPs, do not immediately connect to ketamine use.
2010s — Ketamine is reclassified as a Class B drug in the UK in 2014, reflecting growing concern about its harms. Despite this, prevalence remains high, particularly among 16 to 24 year olds. Global Drug Survey data has consistently shown comparatively high levels of ketamine use in the UK.
2020s — Reported ketamine use remains elevated post-pandemic. Some NHS urology departments have described significant increases in presentations related to ketamine bladder. At the same time, ketamine-assisted therapy gains research attention, adding complexity to public messaging. Services are navigating a substance with an increasingly complex public profile while managing serious harms among their client groups.
What services are dealing with
The clients presenting to services with ketamine-related concerns are often not those services might expect. Many are employed, socially connected young people who do not identify as having a drug problem but are experiencing real physical consequences, including bladder pain, urinary frequency, or dependency, that affect their quality of life.
Ketamine also presents a particular challenge because the gap between occasional recreational use and dependent, harmful use can narrow quickly. Many users remain unaware of the risks until significant damage has occurred. Resources that are honest, accessible, and free from stigmatising language are essential for reaching this group.
Services working with people who use ketamine consistently tell us they need materials that can be used in brief interventions, left in waiting rooms, distributed during outreach, or handed to clients who may not engage with longer conversations. Our resources have been designed with exactly these contexts in mind.
Choosing the right resources for your service
The resources above span different formats and audiences. Whether you need a short ketamine leaflet for initial contact, a detailed resource to support structured ketamine harm reduction conversations, or material that can be adapted for group work, you will find suitable options here.
All resources are produced to a professional standard, are evidence-informed, and use language appropriate for the people your service works with. Bulk ordering is available, and we can also work with you to commission bespoke resources tailored to your specific client group or service context.
